Roche in Oncology Media Fair

BASEL, Switzerland, May 30 /PRNewswire/ --

-- Developing Oncology Solutions

    
                   Friday, 2 June 2006 (9:00 a.m. - 1:00 p.m.)
                         Atlanta Marriott Marquis Hotel
                         (For Non-U.S. Journalists Only)
    WHAT: Exclusive preview of Roche worldwide oncology franchise's
          ground-breaking data.
          Don't miss this unique opportunity to hear first-hand about the
          latest targeted and innovative therapies:
          - Avastin: first anti-angiogenic agent for breast, colorectal and
            non-small cell lung cancer
          - Bondronat: only single nitrogen bisphosphonate for metastatic
            bone disease
          - Herceptin: first biologically engineered, monoclonal antibody
            to treat breast cancer
          - Mabthera: the world's first monoclonal antibody therapy for the
            treatment of non-Hodgkin's lymphoma
          - Tarceva: only EGFR-inhibitor with a survival benefit in lung
            cancer
          - Xeloda: unsurpassed patient convenience with an oral
            chemotherapy regimen for breast and colorectal cancers
    WHY:  -- Preview the latest cancer data from one of the world's premiere
             oncology portfolios
          -- Access to leading oncology experts and Roche senior executives
             in a one-to-one interview format, immediately following the
             Media Fair
    WHERE: Atlanta Marriott Marquis Hotel
           Marquis Ballroom, Salon 3 (Media Fair Exhibit) & Consulate Room
            (Key Data Presentations)
           265 Peachtree Avenue; Atlanta, Georgia USA
    WHEN: Friday, 2 June 2006 (9:00 a.m. to 1:00 p.m.)
    RSVP: To register for this event and to arrange one-to-one interviews,
          please contact Mitti Bose, Shire Health International via phone at
          +1-212-625-7140, mobile +1-917-804-9084 or via e-mail at
          mitti.bose@newyork.shirehealth.com. We suggest you register prior
          to June 2 to secure you're spot at the briefing, however on-site
          registration will be available with a press badge/identification.

Mitti Bose, Shire Health International via phone at +1-212-625-7140, mobile +1-917-804-9084 or via e-mail at mitti.bose@newyork.shirehealth.com